Teladoc Health (TDOC) Research & Development (2016 - 2025)
Historic Research & Development for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $67.6 million.
- Teladoc Health's Research & Development fell 664.66% to $67.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $283.1 million, marking a year-over-year decrease of 1166.89%. This contributed to the annual value of $307.3 million for FY2024, which is 1183.49% down from last year.
- Teladoc Health's Research & Development amounted to $67.6 million in Q3 2025, which was down 664.66% from $68.8 million recorded in Q2 2025.
- Teladoc Health's 5-year Research & Development high stood at $89.9 million for Q4 2023, and its period low was $67.6 million during Q3 2025.
- In the last 5 years, Teladoc Health's Research & Development had a median value of $80.2 million in 2021 and averaged $79.3 million.
- Over the last 5 years, Teladoc Health's Research & Development had its largest YoY gain of 30508.91% in 2021, and its largest YoY loss of 2139.23% in 2021.
- Over the past 5 years, Teladoc Health's Research & Development (Quarter) stood at $72.9 million in 2021, then grew by 13.81% to $82.9 million in 2022, then increased by 8.45% to $89.9 million in 2023, then decreased by 14.66% to $76.8 million in 2024, then dropped by 11.96% to $67.6 million in 2025.
- Its Research & Development was $67.6 million in Q3 2025, compared to $68.8 million in Q2 2025 and $70.0 million in Q1 2025.